Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance (vol 111, pg 2686, 2014)
Journal article published in 2014 by
A. Chatzigeorgiou,
T. Seijkens,
B. Zarzycka,
D. Engel,
M. Poggi,
S. van den Berg,
O. Soehnlein,
H. Winkels,
L. Beckers,
D. Lievens,
A. Driessen 
,
P. Kusters,
E. Biessen,
R. Garcia-Martin,
A. Klotzsche-Von Ameln
and other authors.
,
P. Kusters,
E. Biessen,
R. Garcia-Martin,
A. Klotzsche-Von Ameln
and other authors.
